FORDOZ PHARMA H-1B Visa Sponsorship & Salary Data

The median H-1B salary at FORDOZ PHARMA is $75,500, based on 20 certified filings from FY 2020 to FY 2025. This is 37% lower than the national H-1B median salary of $120,000. Compensation at FORDOZ PHARMA reflects their market positioning, with entry-level roles starting around $68,931 and senior positions reaching $114,999 or higher. These figures represent base salaries in LCA filings and may not include bonuses, equity grants, or other compensation common at large employers.

Salaries at FORDOZ PHARMA range from $62,317 at the 10th percentile to $114,999 at the 90th percentile, showing a $52,682 spread across experience levels and roles. The 25th percentile is $68,931 and the 75th percentile is $88,500.

Yes, FORDOZ PHARMA actively sponsors H-1B visas and has been a consistent participant in the H-1B program. They have filed 20 H-1B labor condition applications from FY 2020 to FY 2025, demonstrating ongoing commitment to hiring international talent. With 20 certified applications and a 0% denial rate, FORDOZ PHARMA maintains a strong track record for H-1B sponsorship. The company sponsors positions across multiple job categories and locations, making them a viable option for professionals seeking H-1B visa sponsorship.

In the most recent fiscal year (FY 2025), FORDOZ PHARMA filed 3 H-1B applications, with 3 certified and 0 denied. Over 6 years of data, FORDOZ PHARMA has consistently demonstrated commitment to H-1B sponsorship.

Note: These are Labor Condition Applications (LCAs) filed with the Department of Labor, which is a prerequisite for H-1B petitions. The actual number of H-1B petitions filed with USCIS may differ.

FORDOZ PHARMA's LCA (Labor Condition Application) denial rate is 0%, with 0 out of 20 applications denied across all years. This translates to a 100.0% certification rate, which indicates how successfully the company prepares and files H-1B applications. A lower denial rate suggests better compliance with Department of Labor requirements, proper wage documentation, and accurate job classification. Prospective H-1B applicants should consider this approval rate alongside other factors like salary, job role, and location when evaluating FORDOZ PHARMA as a potential H-1B sponsor.

This is an excellent approval rate, indicating FORDOZ PHARMA has strong H-1B sponsorship practices and typically meets DOL requirements. Applicants can feel confident in the company's H-1B track record.

FORDOZ PHARMA sponsors H-1B visas for various specialty occupation positions requiring at least a bachelor's degree. Based on 20 certified filings, the most commonly sponsored job titles reflect the company's primary business functions and talent needs. These positions typically require specialized knowledge in fields like technology, engineering, finance, or scientific research. Understanding which roles FORDOZ PHARMA most frequently sponsors can help job seekers target their applications effectively.

Most common H-1B job titles at FORDOZ PHARMA:

The most frequently sponsored role is Research Scientist I with 4 filings at a median salary of $68,931. This is followed by Production Engineer I (3 filings) and Research Scientist.

FORDOZ PHARMA's H-1B positions are distributed across multiple U.S. locations, with concentration in major metropolitan areas and tech hubs. Geographic distribution often reflects company office locations, client sites, and regional market demands. Location significantly impacts H-1B salary due to varying cost of living and local wage requirements. Understanding where FORDOZ PHARMA sponsors H-1B workers can help candidates target specific offices and negotiate appropriate compensation for each market.

Top FORDOZ PHARMA H-1B locations:

The largest H-1B hub for FORDOZ PHARMA is East Windsor, NJ with 20 filings at a median salary of $75,500.

FORDOZ PHARMA's median H-1B salary has increased by +19% from FY 2020 ($59,842) to FY 2025 ($71,431). Tracking salary trends over time reveals how FORDOZ PHARMA adjusts compensation to remain competitive in the H-1B labor market. Salary growth typically reflects inflation adjustments, increased demand for specialized skills, and evolving prevailing wage requirements. These historical trends can help applicants understand future salary expectations and negotiate appropriately when considering H-1B opportunities at FORDOZ PHARMA.

Year-by-year breakdown:

• FY 2021: $88,171 (4 certified)
• FY 2022: $68,931 (4 certified)
• FY 2023: $88,500 (3 certified)
• FY 2024: $88,500 (3 certified)
• FY 2025: $71,431 (3 certified)

FORDOZ PHARMA has maintained steady salary growth for H-1B positions over this period.

FORDOZ PHARMA primarily files H-1B applications at Wage Level I, accounting for 60% of their filings. DOL wage levels range from Level I (entry-level, 17th percentile of local wages) to Level IV (expert, 67th percentile). Wage level determines both salary requirements and, under recent H-1B rules, lottery selection priority. Higher wage levels receive preference in the H-1B lottery, making FORDOZ PHARMA's wage level distribution an important factor for prospective applicants assessing their chances of H-1B selection.

A significant portion of FORDOZ PHARMA's H-1B filings are at entry-level (Level I) wages. These positions may face more competition in the H-1B lottery.

FORDOZ PHARMA's median H-1B salary of $75,500 is 37% lower than the national H-1B median of $120,000 across all employers and industries. This comparison provides context for evaluating FORDOZ PHARMA's competitiveness in attracting H-1B talent. Keep in mind that industry, location, and job function significantly impact salary levels. Tech companies and financial institutions typically offer higher H-1B salaries than other sectors, while salaries in major metros like San Francisco and New York exceed those in smaller markets. Compare FORDOZ PHARMA's offerings with similar companies in your field for a more accurate assessment.

FORDOZ PHARMA's H-1B salaries are below the national median, though this may vary significantly by role, experience level, and location. Consider researching specific positions for more accurate compensation expectations.

Recent H-1B rule changes have increased filing fees and introduced wage-level prioritization in the lottery. FORDOZ PHARMA files 60% of positions at Level I, which may face more lottery competition under wage-level prioritization rules.

With 20 certified filings, FORDOZ PHARMA invests significantly in H-1B sponsorship. The company's 0% denial rate suggests strong compliance with H-1B requirements and documentation standards.

Note: H-1B regulations are subject to change. Fees shown are estimates based on 2024 USCIS fee schedules. Actual costs may vary based on company size, premium processing, and future rule changes.